Shenzhen Neptunus Bioengineering Co Ltd
SZSE:000078
Shenzhen Neptunus Bioengineering Co Ltd
SZSE:000078
Price:
3.61
CNY
4.64%
Market Closed
Market Cap:
¥9.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shenzhen Neptunus Bioengineering Co Ltd
SZSE:000078
|
CN |
Multiples-Based Value
The Multiples-Based Value of one
Shenzhen Neptunus Bioengineering Co Ltd
stock under the Base Case scenario is
10.47
CNY.
Compared to the current market price of 3.61 CNY,
Shenzhen Neptunus Bioengineering Co Ltd
is
Undervalued by 66%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
10.47
CNY
Undervaluation 66%
Multiples Across Competitors
Competitors Multiples
Shenzhen Neptunus Bioengineering Co Ltd Competitors
Shenzhen Neptunus Bioengineering Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Shenzhen Neptunus Bioengineering Co Ltd
SZSE:000078
|
9.5B CNY | 0.3 | -7.8 | -39.8 | -39.8 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
108.8B USD | 0.3 | 25.1 | 17.6 | 19.8 | |
| US |
|
Cencora Inc
NYSE:COR
|
63.2B USD | 0.2 | 38.9 | 13.8 | 17.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.4B USD | 0.2 | 38.4 | 13.6 | 17.2 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.5B USD | 0.2 | 30.4 | 14.7 | 19.1 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.6B AUD | 2.7 | 33.6 | 25 | 25 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.7B CNY | 1.5 | 17.5 | 13.5 | 13.5 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.3B CNY | 0.2 | 11.2 | 8.8 | 8.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 0.6 | 21.5 | 10.5 | 14.7 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.3B HKD | 0.1 | 8.2 | 0.7 | 0.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
